107 related articles for article (PubMed ID: 11075895)
1. Alteplase (TPA) for clotted dialysis catheters.
Hathiwala SC; Hristea I; Khalili V
Int J Artif Organs; 2000 Oct; 23(10):668-9. PubMed ID: 11075895
[No Abstract] [Full Text] [Related]
2. Using alteplase to clear occlusions.
Moureau N
Nursing; 2002 Jan; 32(1):73. PubMed ID: 12926500
[No Abstract] [Full Text] [Related]
3. Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.
Jonker MA; Osterby KR; Vermeulen LC; Kleppin SM; Kudsk KA
JPEN J Parenter Enteral Nutr; 2010; 34(4):444-9. PubMed ID: 20631392
[TBL] [Abstract][Full Text] [Related]
4. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices.
Davis SN; Vermeulen L; Banton J; Schwartz BS; Williams EC
Am J Health Syst Pharm; 2000 Jun; 57(11):1039-45. PubMed ID: 10876745
[TBL] [Abstract][Full Text] [Related]
5. Reteplase for clearance of occluded venous catheters.
Owens L
Am J Health Syst Pharm; 2002 Sep; 59(17):1638-40. PubMed ID: 12224345
[No Abstract] [Full Text] [Related]
6. Alteplase licensed for catheter clearance.
Thompson CA
Am J Health Syst Pharm; 2001 Nov; 58(21):2011, 2014. PubMed ID: 11715818
[No Abstract] [Full Text] [Related]
7. Alteplase (Cathflo Activase).
Middleton G; Ruzevick B
Clin J Oncol Nurs; 2004 Aug; 8(4):417-8, 420. PubMed ID: 15354930
[No Abstract] [Full Text] [Related]
8. Alteplase use for clotted catheters.
Macon EJ
Semin Dial; 2002; 15(1):72. PubMed ID: 11874599
[No Abstract] [Full Text] [Related]
9. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients.
Semba CP; Deitcher SR; Li X; Resnansky L; Tu T; McCluskey ER;
J Vasc Interv Radiol; 2002 Dec; 13(12):1199-205. PubMed ID: 12471182
[TBL] [Abstract][Full Text] [Related]
10. Selection of Single- Versus Double-Lumen Peripherally Inserted Central Catheters and the Influence on Alteplase Use.
Byrne D; Penwarden L
J Infus Nurs; 2018; 41(2):118-121. PubMed ID: 29489707
[TBL] [Abstract][Full Text] [Related]
11. Alteplase for blood flow restoration in hemodialysis catheters: a multicenter, randomized, prospective study comparing "dwell" versus "push" administration.
Vercaigne LM; Zacharias J; Bernstein KN
Clin Nephrol; 2012 Oct; 78(4):287-96. PubMed ID: 22541682
[TBL] [Abstract][Full Text] [Related]
12. Dialysis catheters and recombinant tissue plasminogen activator.
Allon M
N Engl J Med; 2011 May; 364(18):1779; author reply 1779-80. PubMed ID: 21542758
[No Abstract] [Full Text] [Related]
13. Efficacy of alteplase 1 versus 2 mg dose in restoring haemodialysis catheter function (Alte-dose 2): A randomized double-blind controlled study.
El-Masri MM; El Nekidy WS; Soong D; Kadri A
Nephrology (Carlton); 2020 Jun; 25(6):491-496. PubMed ID: 31268610
[TBL] [Abstract][Full Text] [Related]
14. Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial.
Gittins NS; Hunter-Blair YL; Matthews JN; Coulthard MG
Arch Dis Child; 2007 Jun; 92(6):499-501. PubMed ID: 17068072
[TBL] [Abstract][Full Text] [Related]
15. Lytic therapy in central venous catheters for hemodialysis.
McFarland HF; Dinwiddie L; Ferrell J; Forloines-Lynn S
Nephrol Nurs J; 2002 Aug; 29(4):355-60; quiz 361-2. PubMed ID: 12224368
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of management of CVAD occlusions.
Peng C; Monagle P; Newall F
Arch Dis Child; 2011 Sep; 96(9):885-7. PubMed ID: 21398316
[TBL] [Abstract][Full Text] [Related]
17. Interventions for restoring patency of occluded central venous catheter lumens (Review).
van Miert C; Hill R; Jones L
Evid Based Child Health; 2013 Mar; 8(2):695–749. PubMed ID: 24482900
[No Abstract] [Full Text] [Related]
18. Nurse's guide to understanding and treating thrombotic occlusion of central venous access devices.
McKnight S
Medsurg Nurs; 2004 Dec; 13(6):377-82. PubMed ID: 15714740
[TBL] [Abstract][Full Text] [Related]
19. Local low-dose thrombolysis for safe and effective treatment of venous port-catheter thrombosis.
Massmann A; Jagoda P; Kranzhoefer N; Buecker A
Ann Surg Oncol; 2015 May; 22(5):1593-7. PubMed ID: 25287441
[TBL] [Abstract][Full Text] [Related]
20. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
Gabrail N; Sandler E; Charu V; Anas N; Lim E; Blaney M; Ashby M; Gillespie BS; Begelman SM
J Vasc Interv Radiol; 2010 Dec; 21(12):1852-8. PubMed ID: 21111365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]